DELRAY BEACH, Fla.--(BUSINESS WIRE)--XenaCare Holdings, Inc. (OTCBB:XCHO), a company specializing in the marketing and retail distribution of consumer healthcare products, announced today that it is expanding its multimillion dollar national advertising campaign to include direct response mailings, television commercials, national sponsorships and additional print advertising to support the rapidly growing network of retailers carrying Cobroxin, an over-the-counter (OTC) pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain.
